Completed PHASE4 INTERVENTIONAL 2-arm NCT01704612

Evaluation of Block Duration in Type 2 Diabetes Patients (Diabeteblock)

Comparison of Subgluteal Sciatic Nerve Block Duration in Type-2 Diabetic and Non Diabetic Patients

Sponsor: Centre Hospitalier Universitaire de Nīmes

Interventions ropivacaine

Updated 5 times since 2017 Last updated: Dec 21, 2012 Started: Jul 31, 2011 Primary completion: Mar 31, 2012 Completion: Mar 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Diabetes Type 2 and is currently completed. Centre Hospitalier Universitaire de Nīmes leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire de Nīmes
Pierre and Marie Curie University

Data source: Pierre and Marie Curie University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France